Annual CFO:
$239.81M+$96.21M(+67.00%)Summary
- As of today, CPRX annual cash from operations is $239.81 million, with the most recent change of +$96.21 million (+67.00%) on December 31, 2024.
- During the last 3 years, CPRX annual cash from operations has risen by +$179.44 million (+297.22%).
- CPRX annual cash from operations is now at all-time high.
Performance
CPRX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
$32.44M-$38.86M(-54.50%)Summary
- As of today, CPRX quarterly cash from operations is $32.44 million, with the most recent change of -$38.86 million (-54.50%) on September 30, 2025.
- Over the past year, CPRX quarterly cash from operations has dropped by -$40.43 million (-55.49%).
- CPRX quarterly cash from operations is now -55.49% below its all-time high of $72.87 million, reached on September 30, 2024.
Performance
CPRX Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$234.66M-$40.43M(-14.70%)Summary
- As of today, CPRX TTM cash from operations is $234.66 million, with the most recent change of -$40.43 million (-14.70%) on September 30, 2025.
- Over the past year, CPRX TTM cash from operations has increased by +$10.08 million (+4.49%).
- CPRX TTM cash from operations is now -14.70% below its all-time high of $275.09 million, reached on June 30, 2025.
Performance
CPRX TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CPRX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +67.0% | -55.5% | +4.5% |
| 3Y3 Years | +297.2% | -21.5% | +146.6% |
| 5Y5 Years | +592.9% | +183.3% | +430.6% |
CPRX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +297.2% | -55.5% | +168.8% | -14.7% | +146.6% |
| 5Y | 5-Year | at high | +592.9% | -55.5% | +750.5% | -14.7% | +463.6% |
| All-Time | All-Time | at high | +1033.0% | -55.5% | +490.2% | -14.7% | +950.6% |
CPRX Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $32.44M(-54.5%) | $234.66M(-14.7%) |
| Jun 2025 | - | $71.30M(+18.7%) | $275.09M(+2.7%) |
| Mar 2025 | - | $60.04M(-15.3%) | $267.93M(+11.7%) |
| Dec 2024 | $239.81M(+67.0%) | $70.88M(-2.7%) | $239.81M(+6.8%) |
| Sep 2024 | - | $72.87M(+13.6%) | $224.58M(+14.1%) |
| Jun 2024 | - | $64.14M(+100.9%) | $196.84M(+20.4%) |
| Mar 2024 | - | $31.93M(-42.6%) | $163.46M(+13.8%) |
| Dec 2023 | $143.60M(+23.7%) | $55.65M(+23.3%) | $143.60M(+12.2%) |
| Sep 2023 | - | $45.13M(+46.7%) | $128.03M(+3.1%) |
| Jun 2023 | - | $30.75M(+154.8%) | $124.20M(+3.8%) |
| Mar 2023 | - | $12.07M(-69.9%) | $119.64M(+3.1%) |
| Dec 2022 | $116.05M(+92.2%) | $40.08M(-3.0%) | $116.05M(+22.0%) |
| Sep 2022 | - | $41.30M(+57.7%) | $95.15M(+25.9%) |
| Jun 2022 | - | $26.19M(+208.9%) | $75.55M(+16.2%) |
| Mar 2022 | - | $8.48M(-55.8%) | $65.04M(+7.7%) |
| Dec 2021 | $60.37M(+34.1%) | $19.18M(-11.7%) | $60.37M(+11.2%) |
| Sep 2021 | - | $21.71M(+38.5%) | $54.30M(+23.3%) |
| Jun 2021 | - | $15.68M(+311.0%) | $44.05M(+5.8%) |
| Mar 2021 | - | $3.81M(-70.9%) | $41.64M(-7.5%) |
| Dec 2020 | $45.03M(+30.1%) | $13.11M(+14.4%) | $45.03M(+1.8%) |
| Sep 2020 | - | $11.45M(-13.7%) | $44.22M(-9.8%) |
| Jun 2020 | - | $13.27M(+83.9%) | $49.03M(-1.5%) |
| Mar 2020 | - | $7.21M(-41.3%) | $49.79M(+43.8%) |
| Dec 2019 | $34.61M(+234.7%) | $12.29M(-24.4%) | $34.61M(+147.1%) |
| Sep 2019 | - | $16.26M(+16.0%) | $14.01M(+254.6%) |
| Jun 2019 | - | $14.02M(+276.1%) | -$9.06M(+67.2%) |
| Mar 2019 | - | -$7.96M(+4.2%) | -$27.59M(-7.3%) |
| Dec 2018 | -$25.70M(-87.0%) | -$8.31M(-22.2%) | -$25.70M(-20.0%) |
| Sep 2018 | - | -$6.80M(-51.0%) | -$21.42M(-24.2%) |
| Jun 2018 | - | -$4.51M(+25.9%) | -$17.25M(-8.2%) |
| Mar 2018 | - | -$6.08M(-50.9%) | -$15.95M(-16.0%) |
| Dec 2017 | -$13.74M(+23.5%) | -$4.03M(-53.1%) | -$13.74M(+2.7%) |
| Sep 2017 | - | -$2.63M(+17.8%) | -$14.12M(+4.4%) |
| Jun 2017 | - | -$3.20M(+17.5%) | -$14.77M(+7.2%) |
| Mar 2017 | - | -$3.88M(+12.1%) | -$15.91M(+11.4%) |
| Dec 2016 | -$17.96M(+0.3%) | -$4.41M(-34.6%) | -$17.96M(+1.2%) |
| Sep 2016 | - | -$3.28M(+24.5%) | -$18.18M(+10.2%) |
| Jun 2016 | - | -$4.34M(+26.8%) | -$20.25M(-0.5%) |
| Mar 2016 | - | -$5.93M(-28.0%) | -$20.15M(-11.9%) |
| Dec 2015 | -$18.02M | -$4.63M(+13.3%) | -$18.02M(-3.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | -$5.34M(-25.8%) | -$17.36M(-11.5%) |
| Jun 2015 | - | -$4.25M(-11.9%) | -$15.57M(-8.8%) |
| Mar 2015 | - | -$3.79M(+4.6%) | -$14.31M(-10.6%) |
| Dec 2014 | -$12.94M(-31.0%) | -$3.98M(-12.0%) | -$12.94M(+1.1%) |
| Sep 2014 | - | -$3.55M(-19.1%) | -$13.09M(-16.7%) |
| Jun 2014 | - | -$2.98M(-23.0%) | -$11.22M(-11.7%) |
| Mar 2014 | - | -$2.42M(+41.3%) | -$10.05M(-1.8%) |
| Dec 2013 | -$9.88M(-92.1%) | -$4.13M(-145.3%) | -$9.88M(-34.6%) |
| Sep 2013 | - | -$1.68M(+7.1%) | -$7.34M(-8.6%) |
| Jun 2013 | - | -$1.81M(+19.4%) | -$6.76M(-11.0%) |
| Mar 2013 | - | -$2.25M(-41.1%) | -$6.09M(-18.4%) |
| Dec 2012 | -$5.14M(-3.1%) | -$1.59M(-44.8%) | -$5.14M(-3.1%) |
| Sep 2012 | - | -$1.10M(+3.8%) | -$4.98M(+3.0%) |
| Jun 2012 | - | -$1.14M(+12.1%) | -$5.14M(+5.8%) |
| Mar 2012 | - | -$1.30M(+9.5%) | -$5.46M(-9.4%) |
| Dec 2011 | -$4.99M(-32.7%) | -$1.44M(-14.8%) | -$4.99M(-15.5%) |
| Sep 2011 | - | -$1.25M(+14.4%) | -$4.32M(-11.2%) |
| Jun 2011 | - | -$1.46M(-76.0%) | -$3.88M(-8.8%) |
| Mar 2011 | - | -$831.10K(-8.0%) | -$3.57M(+5.1%) |
| Dec 2010 | -$3.76M(+51.1%) | -$769.20K(+5.9%) | -$3.76M(+1.6%) |
| Sep 2010 | - | -$817.30K(+28.9%) | -$3.82M(+12.3%) |
| Jun 2010 | - | -$1.15M(-12.5%) | -$4.35M(+25.8%) |
| Mar 2010 | - | -$1.02M(-23.2%) | -$5.87M(+23.6%) |
| Dec 2009 | -$7.68M(+7.0%) | -$828.90K(+38.7%) | -$7.68M(+21.2%) |
| Sep 2009 | - | -$1.35M(+49.2%) | -$9.75M(+10.7%) |
| Jun 2009 | - | -$2.66M(+6.1%) | -$10.92M(-10.6%) |
| Mar 2009 | - | -$2.84M(+2.2%) | -$9.87M(-19.5%) |
| Dec 2008 | -$8.26M(-86.7%) | -$2.90M(-15.1%) | -$8.26M(-31.3%) |
| Sep 2008 | - | -$2.52M(-56.0%) | -$6.29M(-41.0%) |
| Jun 2008 | - | -$1.62M(-32.0%) | -$4.46M(-4.2%) |
| Mar 2008 | - | -$1.22M(-31.3%) | -$4.28M(+3.2%) |
| Dec 2007 | -$4.42M(-275.5%) | -$932.30K(-34.7%) | -$4.42M(-6.1%) |
| Sep 2007 | - | -$692.10K(+51.8%) | -$4.17M(-17.7%) |
| Jun 2007 | - | -$1.43M(-5.1%) | -$3.54M(-68.0%) |
| Mar 2007 | - | -$1.37M(-101.5%) | -$2.11M(-183.5%) |
| Dec 2006 | -$1.18M(-158.8%) | -$677.70K(-920.6%) | -$744.10K(-1020.6%) |
| Sep 2006 | - | -$66.40K | -$66.40K |
| Dec 2005 | -$455.40K(-97.6%) | - | - |
| Dec 2004 | -$230.50K(+37.0%) | - | - |
| Dec 2003 | -$365.80K | - | - |
FAQ
- What is Catalyst Pharmaceuticals, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. annual cash from operations year-on-year change?
- What is Catalyst Pharmaceuticals, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
- What is Catalyst Pharmaceuticals, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
What is Catalyst Pharmaceuticals, Inc. annual cash from operations?
The current annual cash from operations of CPRX is $239.81M
What is the all-time high annual cash from operations for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high annual cash from operations is $239.81M
What is Catalyst Pharmaceuticals, Inc. annual cash from operations year-on-year change?
Over the past year, CPRX annual cash from operations has changed by +$96.21M (+67.00%)
What is Catalyst Pharmaceuticals, Inc. quarterly cash from operations?
The current quarterly cash from operations of CPRX is $32.44M
What is the all-time high quarterly cash from operations for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high quarterly cash from operations is $72.87M
What is Catalyst Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
Over the past year, CPRX quarterly cash from operations has changed by -$40.43M (-55.49%)
What is Catalyst Pharmaceuticals, Inc. TTM cash from operations?
The current TTM cash from operations of CPRX is $234.66M
What is the all-time high TTM cash from operations for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high TTM cash from operations is $275.09M
What is Catalyst Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
Over the past year, CPRX TTM cash from operations has changed by +$10.08M (+4.49%)